Literature DB >> 19325143

Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.

W Sean Davidson1, R A Gangani D Silva, Sandrine Chantepie, William R Lagor, M John Chapman, Anatol Kontush.   

Abstract

OBJECTIVE: Recent proteomic studies have identified multiple proteins that coisolate with human HDL. We hypothesized that distinct clusters of protein components may distinguish between physicochemically-defined subpopulations of HDL particles, and that such clusters may exert specific biological function(s). METHODS AND
RESULTS: We investigated the distribution of proteins across 5 physicochemically-defined particle subpopulations of normolipidemic human HDL (HDL2b, 2a, 3a, 3b, 3c) fractionated by isopycnic density gradient ultracentrifugation. Liquid chromatography/electrospray mass spectrometry identified a total of 28 distinct HDL-associated proteins. Using an abundance pattern analysis of peptide counts across the HDL subfractions, these proteins could be grouped into 5 distinct classes. A more in-depth correlational network analysis suggested the existence of distinct protein clusters, particularly in the dense HDL3 particles. Levels of specific HDL proteins, primarily apoL-I, PON1, and PON3, correlated with the potent capacity of HDL3 to protect LDL from oxidation.
CONCLUSIONS: These findings suggest that HDL is composed of distinct particles containing unique (apolipo)protein complements. Such subspeciation forms a potential basis for understanding the numerous observed functions of HDL. Further work using additional separation techniques will be required to define these species in more detail.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325143      PMCID: PMC2845307          DOI: 10.1161/ATVBAHA.109.186031

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  39 in total

1.  Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins.

Authors:  Manfred Heller; Daniel Stalder; Evelyn Schlappritzi; Gertraud Hayn; Urs Matter; André Haeberli
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

2.  Comparison of label-free methods for quantifying human proteins by shotgun proteomics.

Authors:  William M Old; Karen Meyer-Arendt; Lauren Aveline-Wolf; Kevin G Pierce; Alex Mendoza; Joel R Sevinsky; Katheryn A Resing; Natalie G Ahn
Journal:  Mol Cell Proteomics       Date:  2005-06-23       Impact factor: 5.911

3.  Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes.

Authors:  April M Shiflett; Joseph R Bishop; Amit Pahwa; Stephen L Hajduk
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

4.  Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.

Authors:  Christian Wolfrum; Matthew N Poy; Markus Stoffel
Journal:  Nat Med       Date:  2005-03-27       Impact factor: 53.440

Review 5.  New insights into the regulation of HDL metabolism and reverse cholesterol transport.

Authors:  Gary F Lewis; Daniel J Rader
Journal:  Circ Res       Date:  2005-06-24       Impact factor: 17.367

6.  Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph.

Authors:  T Ohta; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

7.  Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition.

Authors:  G A Coetzee; A F Strachan; D R van der Westhuyzen; H C Hoppe; M S Jeenah; F C de Beer
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

8.  Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II.

Authors:  M C Cheung; J J Albers
Journal:  J Lipid Res       Date:  1982-07       Impact factor: 5.922

9.  Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films.

Authors:  Y L Marcel; P K Weech; T D Nguyen; R W Milne; W J McConathy
Journal:  Eur J Biochem       Date:  1984-09-17

10.  Distribution of apolipoprotein A-IV in human plasma.

Authors:  C L Bisgaier; O P Sachdev; L Megna; R M Glickman
Journal:  J Lipid Res       Date:  1985-01       Impact factor: 5.922

View more
  167 in total

Review 1.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

2.  LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection.

Authors:  Alexina Orsoni; Samir Saheb; Johannes H M Levels; Geesje Dallinga-Thie; Marielle Atassi; Randa Bittar; Paul Robillard; Eric Bruckert; Anatol Kontush; Alain Carrié; M John Chapman
Journal:  J Lipid Res       Date:  2011-09-26       Impact factor: 5.922

3.  Speciated human high-density lipoprotein protein proximity profiles.

Authors:  Kekulawalage Gauthamadasa; Corina Rosales; Henry J Pownall; Stephen Macha; W Gray Jerome; Rong Huang; R A Gangani D Silva
Journal:  Biochemistry       Date:  2010-11-23       Impact factor: 3.162

4.  Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein.

Authors:  Jonathan D Smith
Journal:  J Clin Lipidol       Date:  2010 Sep-Oct       Impact factor: 4.766

5.  How complicated can it be? The link between APOL1 risk variants and lipoprotein heterogeneity in kidney and cardiovascular diseases.

Authors:  Chien-An A Hu; Patricio E Ray
Journal:  Nephrol Dial Transplant       Date:  2015-10-03       Impact factor: 5.992

Review 6.  High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Authors:  Rui Kuai; Dan Li; Y Eugene Chen; James J Moon; Anna Schwendeman
Journal:  ACS Nano       Date:  2016-02-25       Impact factor: 15.881

7.  Serum amyloid A in uremic HDL promotes inflammation.

Authors:  Thomas Weichhart; Chantal Kopecky; Markus Kubicek; Michael Haidinger; Dominik Döller; Karl Katholnig; Cacang Suarna; Philipp Eller; Markus Tölle; Christopher Gerner; Gerhard J Zlabinger; Markus van der Giet; Walter H Hörl; Roland Stocker; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

8.  Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans.

Authors:  Allison B Andraski; Sasha A Singh; Lang Ho Lee; Hideyuki Higashi; Nathaniel Smith; Bo Zhang; Masanori Aikawa; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-26       Impact factor: 8.311

9.  Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies.

Authors:  Parag H Joshi; Peter P Toth; Seth T Lirette; Michael E Griswold; Joseph M Massaro; Seth S Martin; Michael J Blaha; Krishnaji R Kulkarni; Arif A Khokhar; Adolfo Correa; Ralph B D'Agustino; Steven R Jones
Journal:  Eur J Prev Cardiol       Date:  2014-07-25       Impact factor: 7.804

10.  Evolution of the primate trypanolytic factor APOL1.

Authors:  Russell Thomson; Giulio Genovese; Chelsea Canon; Daniella Kovacsics; Matthew K Higgins; Mark Carrington; Cheryl A Winkler; Jeffrey Kopp; Charles Rotimi; Adebowale Adeyemo; Ayo Doumatey; George Ayodo; Seth L Alper; Martin R Pollak; David J Friedman; Jayne Raper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.